Safety profile of methotrexate used off-label in ectopic pregnancy: an active monitoring study based on a Chinese hospital pharmacovigilance system

References

• ACOG. ACOG practice bulletin no. 193: tubal ectopic pregnancy. Obstet Gynecol. 2018;131(3):e91–e103.
   PubMedGoogle Scholar
• Po L, Thomas J, Mills K, et al. Guideline no. 414: management of pregnancy of unknown location and tubal and nontubal ectopic pregnancies. J Obstet Gynaecol Can. 2021;43(5):614–630.e1. doi:10.1016/j.jogc.2021.01.002.
   PubMed Web of Science ®Google Scholar
• Hajenius PJ, Engelsbel S, Mol BW, et al. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet. 1997;350(9080):774–779. doi:10.1016/s0140-6736(97)05487-1.
   PubMed Web of Science ®Google Scholar
• Krag Moeller LB, Moeller C, Thomsen SG, et al. Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: a randomized trial. Acta Obstet Gynecol Scand. 2009;88(12):1331–1337. doi:10.3109/00016340903188912.
   PubMed Web of Science ®Google Scholar
• Alur-Gupta S, Cooney LG, Senapati S, et al. Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis. Am J Obstet Gynecol. 2019;221(2):95.e2–108.e2. doi:10.1016/j.ajog.2019.01.002.
   Web of Science ®Google Scholar
• Marret H, Fauconnier A, Dubernard G, et al. Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF. Eur J Obstet Gynecol Reprod Biol. 2016; 205:105–109. doi:10.1016/j.ejogrb.2016.07.489.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Y, Gan L, et al. Predictors and clinical features of methotrexate (MTX) therapy for ectopic pregnancy. BMC Pregnancy Childbirth. 2020;20(1):654. doi:10.1186/s12884-020-03350-8.
   PubMed Web of Science ®Google Scholar
• Yang C, Cai J, Geng Y, et al. Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis. Reprod Biomed Online. 2017;34(4):383–391. doi:10.1016/j.rbmo.2017.01.004.
   PubMed Web of Science ®Google Scholar
• Rigopoulos P, Dardalas I, Pourzitaki C. Emphasis on the off-label use of methotrexate for ectopic pregnancy. Am J Obstet Gynecol. 2019;220(6):611–612. doi:10.1016/j.ajog.2019.02.043.
   PubMed Web of Science ®Google Scholar
• Diesel G. Review of adverse events following off-label use of medicines. Vet Rec. 2011;168(8):205–207. doi:10.1136/vr.d1128.
   PubMed Web of Science ®Google Scholar
• Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 1999;88(9):965–968. doi:10.1111/j.1651-2227.1999.tb00191.x.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu C, Xiao L, et al. Low-dose methotrexate-induced renal failure in a patient with ectopic pregnancy: a case report. J Med Case Rep. 2023;17(1):119.
   PubMedGoogle Scholar
• Yu H, Wang W, Liang H, et al. Severe adverse toxic effects of low-dose methotrexate treatment on an ectopic pregnancy patient with methylenetetrahydrofolate reductase mutations: a case report. Front Med. 2021;8:738315. doi:10.3389/fmed.2021.738315.
   Web of Science ®Google Scholar
• Shafie M, Abbaszadeh M, Sharifi F. Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction. Daru. 2021;29(1):205–209. doi:10.1007/s40199-020-00379-0.
   PubMed Web of Science ®Google Scholar
• Bayraktar B. Febrile neutropenia following with single-low-dose methotrexate for the treatment of ectopic pregnancy: a case report. Pan Afr Med J. 2021;38:17. doi:10.11604/pamj.2021.38.17.27507.
   PubMed Web of Science ®Google Scholar
• Gupta D, Kerai S. Intensive care management of multiorgan failure following single low dose methotrexate for ectopic pregnancy: an intriguing case report. Indian J Anaesth. 2019;63(10):870–872. doi:10.4103/ija.IJA_366_19.
   PubMed Web of Science ®Google Scholar
• Brunello J, Guerby P, Cartoux C, et al. Safety considerations regarding methotrexate off-label use in tubal ectopic pregnancy. Arch Gynecol Obstet. 2019;300(4):1095–1096. doi:10.1007/s00404-019-05254-1.
   PubMed Web of Science ®Google Scholar
• Zuo W, Sun Y, Liu R, et al. Management guideline for the off-label use of medicine in China (2021). Expert Rev Clin Pharmacol. 2022;15(10):1253–1268. doi:10.1080/17512433.2022.2120468.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang T, Li G, et al. Pharmacovigilance in China: development and challenges. Int J Clin Pharm. 2018;40(4):823–831. doi:10.1007/s11096-018-0693-x.
   PubMed Web of Science ®Google Scholar
• Sun J, Deng X, Chen X, et al. Incidence of adverse drug reactions in COVID-19 patients in China: an active monitoring study by hospital pharmacovigilance system. Clin Pharmacol Ther. 2020;108(4):791–797. doi:10.1002/cpt.1866.
   PubMed Web of Science ®Google Scholar
• Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20(2):109–117. doi:10.2165/00002018-199920020-00002.
   PubMed Web of Science ®Google Scholar
• US Department of Helth and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. 2017:1–146.
   Google Scholar
• Yuk JS, Lee JH, Park WI, et al. Systematic review and meta-analysis of single-dose and non-single-dose methotrexate protocols in the treatment of ectopic pregnancy. Int J Gynaecol Obstet. 2018;141(3):295–303. doi:10.1002/ijgo.12473.
   PubMed Web of Science ®Google Scholar
• Song T, Kim MK, Kim ML, et al. Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial. Hum Reprod. 2016;31(2):332–338. doi:10.1093/humrep/dev312.
   PubMed Web of Science ®Google Scholar
• Glock JL, Johnson JV, Brumsted JR. Efficacy and safety of single-dose systemic methotrexate in the treatment of ectopic pregnancy. Fertil Steril. 1994;62(4):716–721. doi:10.1016/s0015-0282(16)56994-5.
   PubMed Web of Science ®Google Scholar
• Ding Z, Ye D, Wg L, et al. Efficacy and safety of single-dose methotrexate in the treatment of unruptuerd ectopic pregnancy. Zhonghua Yi Xue Za Zhi. 2003;83(19):1704–1705.
   Google Scholar
• Chen YX, Mao YY, Xie X. Efficacy and side effects of methotrexate in the treatment of ectopic pregnancy. Zhonghua Fu Chan Ke Za Zhi. 2003;38(12):749–751.
   PubMedGoogle Scholar
• Fernandez H, Bourget P, Ville Y, et al. Treatment of unruptured tubal pregnancy with methotrexate: pharmacokinetic analysis of local versus intramuscular administration. Fertil Steril. 1994;62(5):943–947. doi:10.1016/s0015-0282(16)57055-1.
   PubMed Web of Science ®Google Scholar
• Naeh A, Shrim A, Shalom-Paz E, et al. Cesarean scar pregnancy managed with local and systemic methotrexate: a single center case series. Eur J Obstet Gynecol Reprod Biol. 2019;238:138–142. doi:10.1016/j.ejogrb.2019.05.014.
   PubMed Web of Science ®Google Scholar
• Toh J, Deussen A, Yasin N, et al. Cesarean scar ectopic pregnancies: a retrospective case series at an Australian tertiary referral center. Int J Gynaecol Obstet. 2022;159(3):771–775. doi:10.1002/ijgo.14183.
   PubMed Web of Science ®Google Scholar
• Pansky M, Bukovsky I, Golan A, et al. Local methotrexate injection: a nonsurgical treatment of ectopic pregnancy. Am J Obstet Gynecol. 1989;161(2):393–396. doi:10.1016/0002-9378(89)90529-2.
   PubMed Web of Science ®Google Scholar
• Campbell JM, Bateman E, Stephenson MD, et al. Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses. Cancer Chemother Pharmacol. 2016;78(1):27–39. doi:10.1007/s00280-016-3043-5.
   PubMed Web of Science ®Google Scholar
• Castaldo P, Magi S, Nasti AA, et al. Clinical pharmacogenetics of methotrexate. Curr Drug Metab. 2011;12(3):278–286. doi:10.2174/138920011795101840.
   PubMed Web of Science ®Google Scholar
• Lipscomb GH. Medical management of ectopic pregnancy. Clin Obstet Gynecol. 2012;55(2):424–432. doi:10.1097/GRF.0b013e3182510a48.
   PubMed Web of Science ®Google Scholar
• Ayad MW, El Naggar AA, El Naggar M. MTHFR C677T polymorphism: association with lymphoid neoplasm and effect on methotrexate therapy. Eur J Haematol. 2014;93(1):63–69. doi:10.1111/ejh.12302.
   PubMed Web of Science ®Google Scholar
• NICE. National institute for health and care excellence: guidelines. Ectopic pregnancy and miscarriage: diagnosis and initial management. London: National Institute for Health and Care Excellence (NICE); 2021.
   Google Scholar
• Li X, Li H, Deng J, et al. Active pharmacovigilance in China: recent development and future perspectives. Eur J Clin Pharmacol. 2018;74(7):863–871. doi:10.1007/s00228-018-2455-z.
   PubMed Web of Science ®Google Scholar
• Auffret M, Labreuche J, Duhamel A, et al. Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: an example with baclofen and alcohol dependence in France. Drug Saf. 2017;40(3):257–262. doi:10.1007/s40264-016-0489-7.
   PubMed Web of Science ®Google Scholar
• Fabiano V, Mameli C, Zuccotti GV. Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future. Expert Opin Drug Saf. 2012;11(1):95–105. doi:10.1517/14740338.2011.584531.
   PubMed Web of Science ®Google Scholar